Results: What Adults Over 50 Can Realistically Expect Clinical trial data on GLP-1 medications generally skews toward younger to middle-aged adult populations, but real-world evidence and subgroup analyses suggest that adults over 50 achieve meaningful weight loss on these medications, though often at a somewhat slower pace than younger patients
Depending on which part of the brain is affected, a person may experience different symptoms
Semaglutide, traditionally a medication prescribed for type 2 diabetes, has been found to have off-label uses in aiding weight loss
These meals pack more protein into smaller portions, so you can eat less without missing out on nourishment
8 Further analysis of SUSTAIN-6 showed that the majority of the effects were attributed to the magnitude and rapidity of the reduction in HbA1c during the first 16 weeks of treatment in subjects with pre-existing diabetic retinopathy, poor glycaemia control at baseline, and patients treated with insulin